1 citations
,
March 2020 in “Australasian Journal of Dermatology” This report describes five cases of bitemporal alopecia areata with frontal hairline involvement, detailing their management strategies and highlighting potential differential diagnoses, but does not present new clinical results.
1 citations
,
August 2005 in “Springer eBooks” Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.
This case study documented a 36-year-old woman with postpartum-onset frontal fibrosing alopecia who showed significant improvement in hair regrowth after early combination therapy with dutasteride, tofacitinib, and intralesional triamcinolone acetonide, suggesting potential benefits of multimodal treatment in this typically irreversible condition.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study concluded that statins do not independently improve alopecia areata, as age confounds their perceived efficacy.
This study found that both intradermal BCG vaccine and intralesional triamcinolone acetonide were similarly effective for treating patchy alopecia areata, though intralesional triamcinolone was preferable due to fewer side effects associated with BCG vaccine.
August 2025 in “Zanco Journal of Medical Sciences” In this interventional therapeutic study, both intralesional triamcinolone acetonide and vitamin D3 showed significant improvement in alopecia areata, with terminal regrowth more frequently observed in the steroid group, although differences were not statistically significant.
February 2025 in “Journal of Neonatal Surgery” This study reports that non-surgical treatments like triamcinolone acetonide and Botulinum toxin Type A reduced keloid volume by up to 80% in children, with combination therapies being safer and having fewer side effects.
January 2024 in “International Journal of Dermatology Research” In this study, platelet-rich plasma therapy was observed to provide better improvement in hair regrowth for alopecia areata patients than intralesional triamcinolone acetonide, as measured by lower SALT scores.
December 2023 in “JAAD Case Reports” In this study, a 55-year-old man with a localized patch of alopecia areata achieved hair regrowth through intralesional triamcinolone acetonide injections, demonstrating this treatment as an effective initial therapy for localized alopecia areata.
This study reports two cases of severe alopecia areata showing seemingly permanent hair regrowth with a modified triamcinolone acetonide regimen involving epinephrine, and suggests a potential role for epinephrine in enhancing treatment efficacy.
August 2015 in “Dermatología Argentina” This study reviewed 18 postmenopausal women with frontal fibrosing alopecia, noting frontotemporal hairline recession and eyebrow loss, often treated with steroids, triamcinolone, and other medications.
May 2010 in “Journal of the Dermatology Nurses' Association” This article discusses cicatricial alopecias, focusing on diagnosis and management strategies, but reports no new clinical findings.
July 2010 in “British Journal of Dermatology” This article discusses female pattern hair loss and explores potential causes beyond androgenic factors, reporting no new research findings.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study reports that intralesional triamcinolone acetonide was more effective than Vitamin D supplementation in increasing hair density among alopecia areata patients, although Vitamin D also showed significant hair regrowth in patients with low serum vitamin D levels.
2 citations
,
January 2021 in “Clinical dermatology review” This case report describes a promising response to platelet-rich plasma therapy, modified with triamcinolone acetonide, in treating alopecia totalis.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this randomized control trial, the researchers found that intralesional triamcinolone acetonide led to higher hair density increases than Vitamin D supplementation in alopecia areata patients, although potential hair regrowth was also noted with Vitamin D in those with deficient levels.
This comparative clinical study found no statistically significant difference in the remission and recurrence rates between intralesional triamcinolone acetonide and methotrexate for treating localized alopecia areata, suggesting similar efficacy between the two treatments.
October 1966 in “Archives of Dermatology” This abstract reports no research results and details a case presentation of a 19-year-old woman with alopecia universalis treated with DMSO/Fluocinolone Acetonide, providing no new clinical findings.
42 citations
,
August 1987 in “Archives of Dermatology” In this study, 28.5% of patients with extensive alopecia areata had complete hair regrowth during treatment with squaric acid dibutylester, with outcomes linked to shorter alopecia duration and prompt dermatitis development.
3 citations
,
January 1998 in “ACTA HISTOCHEMICA ET CYTOCHEMICA” This study used rapid-freezing immunocytochemistry to successfully map the ultrastructural localization of hair keratins in human scalp hair, primarily finding them in macrofibrils in the cortex and endocuticle.
1 citations
,
September 1977 in “JAMA” This case report describes a 45-year-old man with male pattern baldness who began regrowing hair after receiving fluorouracil treatment for scalp actinic keratosis.
June 2025 in “Indian Journal of Heterocyclic Chemistry” In this study, researchers developed a precise and rapid method for simultaneously analyzing minoxidil and finasteride in local therapeutic formulations, ensuring that the excipients did not interfere, making it suitable for routine quality control.
January 2008 in “Central South Pharmacy” This study developed an accurate and reliable HPLC-ESI-MS method for determining candesartan levels in human plasma, useful for pharmacokinetic studies.
January 2003 in “Pharmaceutical Journal of Chinese People's Liberation Army” This study developed a simple and accurate HPLC method to determine the dissolution of finasteride tablets, achieving a high recovery rate and linear calibration for finasteride detection.
28 citations
,
March 1942 in “Journal of Endocrinology” This article reviews studies on thyroid influence on hair growth, noting varied results, including accelerated growth in some normal and underfed rats after thyroid administration, but reports no clinical results.
6 citations
,
July 2023 in “Plants” This study found that Datura metel extracts obtained through supercritical CO2 extraction demonstrated significant biological activity, including antioxidant and anti-inflammatory properties, and effectively promoted wound closure and collagen preservation, comparable to standard treatments, in laboratory experiments.
June 2026 in “ACS Applied Polymer Materials” This study reports a method for fabricating biofunctional polymer fibers by using DNA-programmable cell-free protein synthesis integrated through solution blow spinning, enabling in situ protein production and potential applications in respirators, sampling swabs, and other advanced materials.
November 2023 in “Indian Journal of Dermatology/Indian journal of dermatology” This article lists essential items for a junior resident's bag in dermatology, detailing their uses to enhance clinical examination skills and preparedness during residency and exams.
10 citations
,
October 1981 in “Archives of Dermatology” This case report describes a 36-year-old man with tinea incognito manifesting as asymptomatic, flat patches of alopecia, which did not improve with standard treatments.
July 2024 in “Clinical Case Reports” This study suggests that young females may experience a rare coexistence of Frontal Fibrosing Alopecia and ophiasis pattern Alopecia Areata, possibly sharing a common underlying pathophysiology.